Treating urine infections is becoming increasingly challenging due to rising antibiotic resistance. Here's what's driving ...

The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...

I’d just disclosed that I thought I had contracted gonorrhoea from kissing a stranger in a club. She said: ‘I haven’t heard ...

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Gepotidacin was non-inferior to ceftriaxone plus azithromycin for the primary outcome of microbiological success. 2. There were no serious or treatment-related adverse events in either group. Evidence ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

Amid the growing antimicrobial resistance, researchers from IIIT Delhi and a French team have developed an AI-tool to tackle ...

With antibiotic-resistant gonorrhea on the rise, the vaccine could provide a way to prevent the disease from spreading.

England will be the first country to offer a gonorrhoea vaccine to high-risk groups, as cases hit record highs and resistance ...